Camlin Fine Sciences Ltd Forensic Report - SOIC x StockScans Report

as of Aug 2026

Camlin Fine Sciences’ record is one of sustained financial strain masked by a large one‑time gain. Consolidated borrowings have risen to ₹720 crore, interest cover has collapsed to 0.6 times, and credit ratings have been downgraded from IND BBB/Negative to IND BBB‑/Stable/IND A3. The group is expanding through a share‑swap acquisition while six overseas subsidiaries and a liquidated entity feed material unaudited losses into the consolidated numbers.

Key findings

  1. Interest cover has collapsed to 0.6x and credit ratings have been downgraded Major - Consolidated borrowings rose to ₹720 crore in FY26, with 51% of that debt maturing within 12 months. Consolidated interest cover fell to 0.56x, and India Ratings downgraded the company’s long‑term bank facilities to IND BBB/Negative in FY25 and further to IND BBB‑/Stable/IND A3 in FY26. Promoter Ashish Dandekar pledged shares to secure ₹29.71 crore of short‑term borrowings at 14-16% p.a., and his total pledge rose from 10.6% to 16.2% of equity with four fresh events adding ₹54.51 crore between March 25 and April 8, 2026.
  2. A ₹102.91 crore liquidation gain masks the underlying loss Major - The group derecognised all liabilities and assets of CFS Europe S.p.A. upon its judicial liquidation, booking a net gain of ₹102.91 crore in the FY26 consolidated profit and loss statement. Management stated the gain arose primarily from derecognising approximately ₹95 crore of loans. Exceptional charges recur across years: FY26 alone carried ₹25.46 crore in provisions for doubtful loans, acquisition costs, and fire losses, while the group left deferred tax assets of ₹39.65 crore unrecognised on ₹154.1 crore of accumulated losses.
  3. The group is expanding, not shrinking, with six unaudited overseas entities Major - The group had 22 subsidiaries and 2 associates at March 31, 2026, up from 21 and 1 a year earlier, after liquidations, a reverse merger, and the Vinpai acquisition. Six subsidiaries incorporated outside India were unaudited for FY26, carrying total assets of ₹34.46 crore and contributing a group share of net loss of ₹11.9 crore. CFS Europe S.p.A., in judicial liquidation from March 17, 2026, contributed a further unaudited total comprehensive loss of ₹91.11 crore for the period April 1, 2025 to March 17, 2026.
  4. Operating cash generation has collapsed and no dividend has been paid since FY2017 Major - Consolidated cash flow from operations fell to ₹26.7 crore in FY25 from ₹139 crore in FY24, and free cash flow turned negative at ₹15.7 crore. Cumulative CFO to EBITDA over ten years stands at 0.52x. Management stated in Q4 FY26 that a “paucity of working capital cycle” and “liquidity crunch” were constraining business execution, and that the cash burn from discontinued operations was “around INR50 crores, INR60 crores every year”.
  5. Audit opinions are unqualified, but the database audit trail has been disabled for three years Major - The statutory auditor issued unqualified opinions on all standalone and consolidated financial statements from FY21 through FY26. The auditor reported that the audit trail at the database level of the holding company’s accounting software was not enabled to capture direct data changes for FY26 and FY25. The consolidated audit scope excludes unaudited subsidiaries that together contributed a group share of total net loss of ₹11.9 crore in FY26.
  6. Related‑party trade receivables have ranged from ₹240 crore to ₹371 crore since FY20 Minor - Standalone trade receivables from related parties stood at ₹282.84 crore as at March 31, 2025, and have ranged between ₹240.12 crore and ₹370.65 crore every year since FY20. The auditor’s CARO report for FY25 notes that principal and interest on a loan to a non‑subsidiary company were due but have not been collected. A fully‑provided loan of ₹2.42 crore to a shuttered subsidiary, Solentus North America Inc., has persisted on the books since at least FY19.

What to watch

Bottom line: This is a disclosed but deeply strained record where a large liquidation gain obscures the erosion of operating cash flow and the weight of subsidiary losses. The risk is structural: an expanding group sits alongside a new acquisition whose economics are not yet priced, while debt is short‑tenor, promoter‑backed, and growing. Watch the FY27 debt maturities, the Vinpai purchase‑price allocation, and whether the unaudited subsidiary losses persist.